Month: March 2026

Inflammatory Biomarker Tracking Predicted to Enhance  Response to 3-D Bio-Printed Therapies Expands OneTest for Longevity with Chronic Kidney Disease Risk Assessment GAITHERSBURG, Md., March 24, 2026 (GLOBE NEWSWIRE) — 20/20 BioLabs, Inc. (“20/20”), 20/20 BioLabs (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that it has entered into an exclusive U.S. technology license and access agreement with ROKIT Healthcare Inc. (“ROKIT”), a global innovator in chronic disease prediction and regenerative health technologies. Under the agreement, 20/20 will integrate ROKIT’s proprietary chronic kidney disease (CKD) prediction algorithm into the 20/20 Longevity Platform, expanding its suite of biomarker-based...

Opening Establishes a Foundation for Multi-Province Growth Across China and Reinforces Reborn Coffee’s Broader International Expansion Strategy BREA, Calif., March 24, 2026 (GLOBE NEWSWIRE) — Reborn Coffee Inc. (Nasdaq: REBN) (the “Company”), a leader in the specialty coffee market, announced today the successful grand opening of its flagship location in Shenzhen, China on March 18, 2026. Located within Tencent’s new headquarters campus, the opening marks a significant milestone in Reborn Coffee’s international growth strategy and further advances the Company’s previously announced expansion initiatives in China. The Shenzhen flagship reflects the Company’s broader strategy to build a scalable presence across multiple provinces in China. As one of China’s leading centers of technology, innovation, and modern urban development, Shenzhen...

CORSICANA, Texas, March 24, 2026 (GLOBE NEWSWIRE) — Birchtech Corp. (NYSE American: BCHT) (TSX: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today announced that it will release financial results for the fourth quarter ended December 31, 2025, after market close on Tuesday, March 31, 2026. Management will host an investor conference call at 5:00 p.m. Eastern time on Tuesday, March 31, 2026, to discuss Birchtech’s fourth quarter 2025 financial results and provide a corporate update. To participate, please use the following information: Fourth Quarter 2025 Earnings Conference Call Date: Tuesday, March 31, 2026Time: 5:00 p.m. Eastern timeU.S./Canada Dial-in: 1-877-407-0792International Dial-in: 1-201-689-8263Conference ID: 13759505Webcast: BCHT...

AI Co-Pilot, TwinX, and HyprX Solutions Demonstrated as Part of the Company’s Results-Oriented AI Delivery Model MAKATI, Philippines, March 24, 2026 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), a global technology company providing enterprise clients with intelligent customer communication software and services powered by artificial intelligence (“AI”), today announced that it showcased its AI product portfolio in the Philippines during an event titled “Rise of AI Labor.” Held at the Makati Shangri-La Hotel in Makati City, the event brought together industry partners, enterprise customers, and technology leaders to explore how AI can scale human expertise and transform business process outsourcing (“BPO”). The Company’s approach to integrating AI with operational delivery to produce measurable...

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) — Satellogic, Inc. (NASDAQ: SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, today announced a new subcontract agreement with Innovative Defense Technologies (IDT) to support the U.S. Office of Naval Research (ONR). This agreement extends the ongoing Slingshot program, an R&D initiative alongside commercial partner GRVTY, focused on accelerated maritime intelligence and low-latency orbital processing. Following the success of Slingshot I, the new phases represent a significant expansion of the program’s scale and technical sophistication:Slingshot II (Summer 2026): Provides a temporal extension of service for two Inter-Satellite Link (ISL)-equipped NewSat Mark V satellites. Slingshot III (2027):...

WEST PALM BEACH, FL, March 24, 2026 (GLOBE NEWSWIRE) — AVAX One Technology Ltd. (Nasdaq: AVX) (“AVAX One” or the “Company”), today announced that it will host a conference call on Tuesday, March 31, 2026 at 5:00 p.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year ended December 31, 2025. The Company plans to release its financial results in a press release prior to the call. AVAX One’s management team will host the conference call, followed by a question-and-answer period. Conference Call and Webcast Details Date: Tuesday, March 31, 2026Time: 5:00 p.m. ETToll-free dial-in number: (877) 407-8037International dial-in number: (201) 689-8037Webcast: AVAX One’s Q4 & FY 2025 Earnings Conference Call Participants can also access the Company’s earnings call using the call...

Preclinical data demonstrates leronlimab-mediated CCR5 inhibition enhances Temozolomide and radiation response in Glioblastoma  Leronlimab demonstrates synergy with standard-of-care therapies, supports plan for prospective combination study VANCOUVER, Washington, March 24, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic triple-negative breast cancer (“mTNBC”) and colorectal cancer (“mCRC”), today announced the presentation of new preclinical and translational data supporting the potential role of CCR5 inhibition in glioblastoma multiforme (GBM) at AACR Special Conference...

Rigorous Pathogen Testing and Proven Preservation Results Drive SteraMist Adoption at Major Mexican Dairy Facility FREDERICK, Md., March 24, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today revealed that a leading Mexican dairy manufacturer has secured ongoing SteraMist iHP services to maintain its high-standard facility sanitation. TOMI’s long-standing relationship with DisinfectCare has facilitated the implementation of SteraMist service at a major dairy facility in Mexico. Prior to purchase, DisinfectCare conducted multiple efficacy studies at the manufacturer’s site by evaluating SteraMist iHP by applying directly on cheese and assessing the efficacy against key industry pathogens, including Staphylococcus aureus, Total coliforms,...

Reflects Strategic Action to Expand Premium Earning Asset Base and Increase Earnings Power and Dividend Capacity NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today announced that it has taken delivery of the Genco Valkyrie, the second of two 2020-built 208,000 dwt scrubber-fitted Newcastlemax vessels that Genco agreed to acquire in November 2025. John C. Wobensmith, Chairman and Chief Executive Officer, commented, “We are pleased to complete the delivery of our second high-specification Newcastlemax vessel this year, during a period of continued strength in the drybulk market. Consistent with our first delivery earlier this month, the vessel will be deployed...

Being Published in the Journal of Vascular and Interventional Radiology, a Premier Peer-Reviewed Journal, Speaks to the Quality and Impact of the Study Company Remains Focused on Expanding Evidence-Based Data to Support Broader Commercial Adoption of the LIBERTY System HINGHAM, Mass., March 24, 2026 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, which is already garnering medical and industry attention, today announced the publication of an article in the Journal of Vascular and Interventional Radiology (JVIR), titled “In Vivo Evaluation of a Disposable Endovascular Robotic System for Arterial Peripheral Vascular Interventions: A Multicenter Feasibility Study.” The article’s first author, Dr. Francois Cornelis, is a leading interventional...